Will European Stem Cell Ruling Stifle Research?
My commentary on patenting stem cell techniques was published by LexisNexis and is available to view here.
Latest news and views tagged Patents
RSSProtect Your Position – Bristol-Myers buys Inhibitex for $2.5 billion
With the Patent Cliff looming and the lack of new drugs to fill the void keeping big Pharma bosses awake at night, we are seeing new strategies emerging in an attempt to off see the gloom and doom predictions...
AstraZeneca takes step forward to find partners to avoid effects of looming Patent Cliff
AstraZeneca, the UK's second biggest pharmaceutical company, has taken steps to counteract the severe consequences of the Patent Cliff. The Patent Cliff is the name given to the imminent loss of revenues...
Pharma industry sleepwalking into jump off patent cliff – survey
The pharmaceutical industry is sleepwalking to the edge of the patent cliff blindfolded. And there's going to be a huge drop this year with revenues falling by up to 40% as the big pharma companies will...
Government proposes change in law to make UK a better place to carry out drug research on patented products
The UK Government would like to change the law to make the UK a more amenable place to carry out clinical trials. There is an exemption from breach of patented pharmaceutical products when the use is in...
“The Patent Cliff – Lipitor goes over the Edge”
As the largest ever number of patents protecting the pharmaceutical industry’s most profitable “blockbuster” drugs are set to expire, for India and China it’s going to be a very merry Christmas...
OFT investigates pharma sector patent settlement agreements
The Office of Fair Trading has announced that it is investigating patent litigation agreements relating to paroxetine. Paroxetine is a medicine used in the treatment of disorders such as depression and...
Supreme Court awards patent for human protein and discovery of underlying gene sequence as it says English courts should follow European Patent Office Technical Board of Appeal where it has adopted a consistent approach – Human Genome Sciences v Eli Lilly, Supreme Court
HGS made a patent application for the human protein Neutrokine-alpha and the discovery of its underlying gene sequence. Eli Lilly challenged the patent application in the High Court and the European Patent...
Another appeal against exclusion from patentability allowed by the High Court – Re Protecting Kids the World Over Ltd, High Court
Following the decision of the High Court in Halliburton, the High Court has now allowed an appeal against the decision of an Intellectual Property Office (IPO) hearing officer that had prevented the registration...
Patent application allowed after rejection for mental act
Hewlett-Packard applied to register a patent for a computer implemented method of selecting an image to insert into an electronic document. An Intellectual Property Office examiner initially rejected the...
